David Einhorn - DME Capital Management, LP

David Einhorn - DME Capital Management

Period:    Q1 2026
Portfolio date:    31 Mar 2026
No. of stocks:    45
Portfolio value:    $3,190,735,190

Holdings Activity Buys Sells History

Holding/activity history for Neubase Therapeutics Inc (NBSE)

Period	Shares	% of Portfolio	Activity	% Change to Portfolio	Price	Value	Filing
2024 Q2	0	0.00	Sell 100.00%	<0.01			SEC
2024 Q1	136,350	<0.01			$0.45	$61,344	SEC
2023 Q4	136,350	<0.01			$0.74	$100,912	SEC
2023 Q3	136,350	<0.01			$0.87	$118,597	SEC
2023 Q2	136,350	0.01	Buy	0.01	$1.87	$254,975	SEC